The Comparative Pathology of Human and Mouse Mammary Glands
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The mouse has emerged as a primary animal modelfor human breast cancer because the mammary glands ofthe two species are very similar in structure andfunction. In this regard the TDLU4 and LAhave similar morphology. The mouse, infected by MMTV,develops "spontaneous" tumors with specificbut limited tumor phenotypes. The advent of geneticmanipulation has created transgenic mice that develophyperplasias and tumors morphologically and cytochemicallycomparable to lesions in humans. Even experiencedpathologists have difficulty distinguishing betweenlesions from the two species, and the morphologicalsimilarities support the utility of the mouse model inunderstanding human breast cancer. In this essay wereview our experience with the histopathology of humanand mouse mammary disease by comparing the normal gland with hyperplastic, dysplastic and neoplasticlesions of traditional and transgenic origin.
J. M. Hamilton (1974). Comparative aspects of mammary tumors. Adv. Cancer Res. 19:1–45.
J. Russo, B. A. Gusterson, A. E. Rogers, I. H. Russo, S. R. Wellings, and M. J. van Zwieten (1990). Comparative study of human and rat mammary tumorigenesis. Lab Invest. 62:244–278.
W. J. Muller (1991). Expression of activated oncogenes in the murine mammary gland: Transgenic models for human breast cancer. Cancer Metast. Rev. 10:217–227.
R. D. Cardiff (1996). The biology of mammary transgenes: Five rules. J. Mam. Gland Biol. Neoplasia 1:61–73.
R. D. Cardiff, E. Sinn, W. Muller, and P. Leder (1991). Transgenic oncogene mice. Tumor phenotype predicts genotype. Am. J. Pathol. 139:495–501.
S. R. Wellings, H. M. Jensen, and R. G. Marcum (1975). An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl. Cancer Inst. 55:231–273.
S. R. Wellings, H. M. Jensen, and M. R. DeVault (1976). Persistent and atypical lobules in the human breast may be precancerous. Experientia 32:1463–1465.
R. D. Cardiff, S. R. Wellings, and L. J. Faulkin (1977). Biology of breast preneoplasia. Cancer 39:2734–2746.
R. R. Anderson (1978). Development Of Mammary Gland In B.L. Larson and V.R. Smith, (eds.), Lactation: A Comprehensive Treatise, Academic Press, New York 4:3–40.
J. R. Harris, S. Hellman, I. C. Henderson, and D. W. Kinne (1996). Breast Diseases, Lippicott-Raven, Philadelphia.
R. Dulbecco, M. Henahan, and B. Armstrong (1982). Cell types and morphogenesis in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 79:7346–7350.
R. D. Cardiff (1998). Are the TDLU of the human the same as the LA of mice? J. Mam. Gland Biol. Neoplasia 3:3–5.
I. H. Russo and J. Russo (1998). Role of hormones in mammary cancer initiation and progression. J. Mam. Gland Biol. Neoplasia 3:49–62.
S. A. Bartow (1998). Use of the autopsy in study ontogeny and expression of the estrogen receptor gene in human breast. J. Mam. Gland Biol. Neoplasia 3:37–48.
J. L. Fendrick, A.M. Raafat, and S.Z. Haslam (1998). Mammary gland growth and development from the postnatal period to postmeonopause: Ovarian steroid receptor ontogeny and regulation the mouse. J. Mam. Gland Biol. Neoplasia 3:7–22.
S. R. Wellings (1980). Development of human breast cancer. Adv. Cancer Res. 31:287–314.
S. R. Wellings (1980). A hypothesis of the origin of human breast cancer from the terminal ductal lobular unit. Pathol. Res. Pract. 166:515–535.
R. S. Rudland (1987). Stem cells and the development of mammary cancers in experimental rats and in humans. Cancer Metast. Rev. 6:55–83.
G. H. Smith and D. Medina (1988). A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J. Cell Sci. 90:173–183.
E. C. Kordon and G. H. Smith (1998). An entire functional mammary gland may comprise the progeny from a single cell. Development 125:1921–1930.
S. Nandi, R. C. Guzman, and J. Yang (1995). Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc. Natl. Acad. Sci. U.S.A. 92:3650–3657.
D. L. Page (1989). Pathology of preinvasive and early breast cancer. Curr. Opin. Oncol. 1:277–283.
D. DeLeon, M.B. Zelinski-Wooten, and M.S. Barkely (1990). Hormonal basis of variation in oestrus cyclicity in selected strains of mice. J. Reprod. Fertil. 89:117–126.
F. Squartini, F. Basolo, and M. Bistocchi (1983). Lobuloacveolar differentiation and tumorigenesis: two separate activities of mouse mammary tumor virus. Cancer Res. 43:5879–5882.
V. M. Weaver, A. H. Fischer, O. W. Peterson, and M. J. Bissell (1996). The importance of the microenvironment in breast cancer progression: Recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem. Cell Biol. 74:833–851.
R. C. Hovey, T.B. McFadden, and R. M. Akers, (1998). Regulation of mammary gland growth and morphogenesis by the mammary fat pad: A species comparison. J. Mam. Gland Biol. Neoplasia 4(1):53–68.
H. Vorheer (1978). Human lactation and breast feeding. In B.L. Larson and V. R. Smith (eds.), Lactation: A Comprehensive Treatise, Academic Press, New York, 4: 182–280.
A. K. Lascelles and C.S. Lee (1978). Involution of the Mammary Gland. Lactation: A Comprehensive Treatise. B.L. Larson and V.R. Smith, (eds.), Academic Press, New York, 4:115–179.
R. Strange, R. R. Friis, L. T. Bemis, and F. J. Geske (1995). Programmed cell death during mammary gland involution. Methods Cell Biol. 46:355–368.
L. J. Beuving (1969). Effects of ovariectomy on preneoplastic nodule formation and maintenance in the mammary glands of carcinogen-treated rats. J. Natl. Cancer Inst. 43:1181–1189.
F. A. Tavassoli (1997). The influence of endogenous and exogenous reproductive hormones on the mammary glands with emphasis on experimental studies in rhesus monkeys. Verh. Dtsch. Ges. Pathol. 81:514–520.
D. M. Ornitz, R. W. Moreadith, and P. Leder (1991). Binary system for regulating transgene expression in mice: Targeting int-2 gene expression with yeast GAL4/UAS control elements. Proc. Natl. Acad. Sci. U.S.A. 88:698–702.
D. Gallahan, C. Jhappan, G. Robinson, L. Hennighausen, R. Sharp, E. Kordon, R. Callahan, G. Merlino, and G. H. Smith (1996). Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res. 56:1775–1785.
C. Jhappan, A. G. Geiser, E. C. Kordon, D. Bagheri, L. Hennighausen, A. B. Roberts, G. H. Smith, and G. Merlino (1993). Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J. 12:1835–1845.
C. T. Guy, S. K. Muthuswamy, R. D. Cardiff, P. Soriano, and W. J. Muller (1994). Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev. 8:23–32.
P. Sicinski, J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630.
D. M. Ornitz, R. D. Cardiff, A. Kuo, and P. Leder (1992). Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants. J. Natl. Cancer Inst. 84:887–892.
C. T. Guy, R. D. Cardiff, and W. J. Muller (1992). Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell Biol. 12:954–961.
A. Tehranian, D. W. Morris, B. H. Min, D. J. Bird, R. D. Cardiff, and P. A. Barry (1996). Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene. Am. J. Pathol. 149:1177–1191.
W. J. Muller, C. L. Arteaga, S. K. Muthuswamy, P. M. Siegel, M. A. Webster, R. D. Cardiff, K. S. Meise, F. Li, S. A. Halter, and R. J. Coffey (1996). Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice. Mol. Cell Biol. 16:5726–5736.
S. A. Halter, P. Dempsey, Y. Matsui, M. K. Stokes, R. Graves-Deal, B. L. Hogan, and R. J. Coffey (1992). Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-alpha. Characterization of mammary gland and skin proliferations. Am. J. Pathol. 140:1131–1146.
G. H. Smith, R. Sharp, E. C. Kordon, C. Jhappan, and G. Merlino (1995). Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am. J. Pathol. 147:1081–1096.
M. A. Webster, J. N. Hutchinson, M. J. Rauh, S. K. Muthuswamy, M. Anton, C. G. Tortorice, R. D. Cardiff, F. L. Graham, J. A. Hassell, and W. J. Muller (1998). Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell Biol. 18:2344–2359.
M. A. Webster, R. D. Cardiff, and W. J. Muller (1995). Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene. Proc. Natl. Acad. Sci. U.S.A. 92:7849–7853.
C. Jhappan, D. Gallahan, C. Stahle, E. Chu, G. H. Smith, G. Merlino, and R. Callahan (1992). Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev. 6:345–355.
T. C. Wang, R. D. Cardiff, L. Zukerberg, E. Lees, A. Arnold, and E. V. Schmidt (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669–671.
W. D. Dupont and D. L. Page (1985). Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med. 312:146–151.
N. A. Consensus Report (1986). Is ‘fibrocystic disease’ of the breast precancerous? Arch. Pathol. Lab. Med. 110:171–173.
C. A. Bodian, K. H. Perzin, R. Lattes, P. Hoffmann, and T. G. Abernathy (1993). Prognostic significance of benign proliferative breast disease [see comments]. Cancer 71:3896–3907.
R. D. Cardiff (1984). Protoneoplasia: The molecular biology of murine mammary hyperplasia. Adv. Cancer Res. 42:167–190.
K. B. DeOme, M. J. Miyamoto, R. C. Osborn, R. C. Guzman, and K. Lum (1978). Detection of inapparent nodule-transformed cells in the mammary gland tissues of virgin female BALB/cfC3H mice. Cancer Res. 38:2103–2111.
H. M. Jensen, J. R. Rice, and S. R. Wellings (1976). Preneoplastic lesions in the human breast. Science 191:295–297.
H. M. Jensen and S. R. Wellings (1976). Preneoplastic lesions of the human mammary gland transplanted into the nude athymic mouse. Cancer Res. 36:2605–2610.
L. J. Faulkin, D. J. Mitchell, L. J. Young, D. W. Morris, R. W. Malone, R. D. Cardiff, and M. B. Gardner (1984). Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus. J. Natl. Cancer Inst. 73:971–982.
C. W. Daniel, K. B. De Ome, J. T. Young, P. B. Blair, and L. J. Faulkin, Jr. (1968). The in vivo life span of normal and preneoplastic mouse mammary glands: A serial transplantation study. Proc. Natl. Acad. Sci. U.S.A. 61:53–60.
D. W. Morris, P. A. Barry, H. D. Bradshaw, Jr., and R. D. Cardiff (1990). Insertion mutation of the int-1 and int-2 loci by mouse mammary tumor virus in premalignant and malignant neoplasms from the GR mouse strain. J. Virol. 64:1794–1802.
L. Bouchard, L. Lamarre, P. J. Tremblay, and P. Jolicoeur (1989). Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57:931–936.
N. Tulchin, F.S. Lee, L. Ornstein, J. Strauchen, and R.D. Cardiff (1995). c-myc protein distribution: Mammary adenocarcinomas of MTV/MYC transgenic mice. Int'l. J. Oncol. 7:5–9.
K. Weijer, K. W. Head, W. Misdorp, and J. F. Hampe (1972). Feline malignant mammary tumors. I. Morphology and biology: Some comparisons with human and canine mammary carcinomas. J. Natl. Cancer Inst. 49:1697–1704.
M. M. Mason, A. E. Bogden, V. Ilievski, H. J. Esber, J. R. Baker, and H. C. Chopra (1972). History of a rhesus monkey adenocarcinoma containing virus particles resembling oncogenic RNA viruses. J. Natl. Cancer Inst. 48:1323–1331.
T. Dunn (1959). Morphology of mammary tumors in mice. In F. Homburger (ed.), Physiopathology of Cancer. A. J. Phiebig: New York., pp. 38–83.
W. J. Muller, F. S. Lee, C. Dickson, G. Peters, P. Pattengale, and P. Leder (1990). The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J. 9:907–913.
T. F. Lane and P. Leder (1997). Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice. Oncogene 15:2133–2144.
R. J. Munn, M. Webster, W. J. Muller, and R. D. Cardiff (1995). Histopathology of transgenic mouse mammary tumors (a short atlas). Semin. Cancer Biol. 6:153–158.
W. J. Muller, E. Sinn, P. K. Pattengale, R. Wallace, and P. Leder (1988). Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105–115.
C. T. Guy, R. D. Cardiff, and W. J. Muller (1996). Activated neu induces rapid tumor progression. J. Biol. Chem. 271:7673–7678.
C. T. Guy, M. A. Webster, M. Schaller, T. J. Parsons, R. D. Cardiff, and W. J. Muller (1992). Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. U.S.A. 89:10578–10582.
D. M. Barnes, J. Bartkova, R. S. Camplejohn, W. J. Gullick, P. J. Smith, and R. R. Millis (1992). Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? Eur. J. Cancer 28:644–648.
T. J. Liang, A. E. Reid, R. Xavier, R. D. Cardiff, and T. C. Wang (1996). Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors. J. Clin. Invest. 97:2872–2877.
J. F. Nelson, K. Karelus, M. D. Bergman, and L. S. Felicio (1995). Neuroendocrine involvement in aging: Evidence from studies of reproductive aging and caloric restriction. Neurobiol. Aging 16:837–843; see discussion pp. 855–856.
J. Vaage and J. P. Harlos (1987). Spontaneous metastasis from primary C3H mouse mammary tumors. Cancer Res. 47:547–550.
L. L. Colombo, D. E. Gomez, L. Puricelli, M. C. Vidal, R. Ponzio, and E. Bal de Kier Joffe (1990). In vivo selection and characterization of a murine mammary tumor subline with high potential for spontaneous lymph node metastasis. J. Surg. Oncol. 45:190–195.
S. F. Juacaba, E. Horak, J. E. Price, and D. Tarin (1989). Tumor cell dissemination patterns and metastasis of murine mammary carcinoma. Cancer Res. 49:570–575.
E. N. Unemori, N. Ways, and D. R. Pitelka (1984). Metastasis of murine mammary tumour lines from the mammary gland and ectopic sites. Brit. J. Cancer. 49:603–614.
D. R. Pitelka, S. T. Hamamoto, and B. N. Taggart (1980). Basal lamina and tissue recognition in malignant mammary tumors. Cancer Res. 40:1600–1611.
R. Callahan (1996). MMTV-induced mutations in mouse mammary tumors: Their potential relevance to human breast cancer. Breast Cancer Res. Treat. 39:33–44.
- The Comparative Pathology of Human and Mouse Mammary Glands
Journal of Mammary Gland Biology and Neoplasia
Volume 4, Issue 1 , pp 105-122
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- COMPARATIVE HISTOPATHOLOGY
- MAMMARY GLAND
- BREAST CANCER
- BREAST DISEASES
- Industry Sectors